• FirefoxInstall the new Firefox »
  •  Dow Down0.45% Nasdaq Down0.49%

    TherapeuticsMD, Inc. (TXMD)

    5.07 Down 0.27(5.06%) Feb 27, 4:04PM EST
    |After Hours : 5.32 Up 0.25 (4.93%) Feb 27, 6:48PM EST
    Add to Portfolio
    ProfileGet Profile for:
    TherapeuticsMD, Inc.
    6800 Broken Sound Parkway NW
    Third Floor
    Boca Raton, FL 33487
    United States - Map
    Phone: 561-961-1900
    Website: http://www.therapeuticsmd.com

    Index Membership:N/A
    Industry:Drug Manufacturers - Major
    Full Time Employees:96

    Business Summary 

    TherapeuticsMD, Inc. operates as a women’s health care product company. The company manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins and cosmetics. It offers prenatal vitamins, iron supplements, vitamin D supplements, natural menopause relief products, and cosmetic stretch mark creams under the vitaMedMD brand, as well as duplicate formulations of its prescription prenatal vitamins products under the BocaGreenMD Prena1 name. The company also focuses on conducting the clinical trials for hormone therapy pharmaceutical products that are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and vaginal dryness. TherapeuticsMD markets its products primarily through a direct national sales force to health care providers, as well as directly through its Website. The company was founded in 2008 and is headquartered in Boca Raton, Florida.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on TherapeuticsMD, Inc.

    Corporate Governance 
    TherapeuticsMD, Inc.’s ISS Governance QuickScore as of Feb 1, 2015 is 7. The pillar scores are Audit: 2; Board: 8; Shareholder Rights: 2; Compensation: 10.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Mr. Robert G. Finizio , 43
    Co-Founder, Chief Exec. Officer and Director
    Mr. John C. K. Milligan IV, 53
    Pres, Sec. and Director
    Mr. Daniel A. Cartwright , 57
    Chief Financial Officer, Principal Accounting Officer, VP of Fin. and Treasurer
    Mr. Mitchell L. Krassan , 49
    Chief Strategy Officer and Exec. VP
    Dr. Brian A. Bernick M.D., 47
    Chief Clinical Officer and Director
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders